2022 Winner • Research and Development Awards
Ochre Bio
Best Chronic Liver Disease RNA Therapies Developer 2022
Scroll to keep reading
Ochre Bio
Best Chronic Liver Disease RNA Therapies Developer 2022
<p>Ochre Bio is a biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of genomic deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for important liver health challenges, from increasing donor liver supply to reducing cirrhosis complications.</p>
Our Trusted Brands
Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have 14 unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.
